Select Your Region
LACTEL® 75:25 DL-PLGE, IV 0.80-1.20 is an innovative controlled-release excipient with an ester-terminated lactide-glycolide base with a mol ratio of 75:25. With an inherent viscosity of 0.80─1.20 dL/g in HFIP and a degredation period of 6 months, LACTEL® 75:25 DL-PLGE offers excellent stability and performance in controlled drug release applications.
LACTEL® 75:25 DL-PLGE, IV 0.80-1.20 is a functional excipient from Evonik containing a 75:25 mol ratio of D,L-Lactide and Glycolide with a uniform degredation period of 6 months for controlled drug delivery. It is compatible with numerous substance types ranging from peptides and proteins to nanoparticles and microparticles in the formulation of long-acting injectable formulations in veterinary medicine and human generic drug formulations.
Physical state: Solid
Form: Granules or pellets
Color: White to yellowish, off-white to light tan
Inherent viscosity (IV) dL/g: 0.80─1.20 (in chloroform)
Degradation time: <6 months
Density (g/mL): 1.30
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry: Poly(DL-lactide-co-glycolide)
Human generic drug formulations Long-acting injectable formulations Price sensitive applications veterinary medicine
Your document download will begin shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you for your inquiry and interest in ChemPoint.
We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you for your inquiry and interest in ChemPoint.
We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
The document currently is provided in the following languages from the supplier at this time.
The document currently is provided in the following languages from the supplier at this time.
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States